Cargando…
Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved?
Cognitive dysfunction is one of the most severe nonmotor symptoms of nigrostriatal impairment. This occurs as a result of profound functional and morphological changes of different neuronal circuits, including modifications in the plasticity and architecture of hippocampal synapses. Such alterations...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263115/ https://www.ncbi.nlm.nih.gov/pubmed/32466659 http://dx.doi.org/10.1177/1759091420925977 |
_version_ | 1783540744010596352 |
---|---|
author | Herrera, Macarena L. Deza-Ponzio, Romina Ghersi, Marisa S. de la Villarmois, Emilce A. Virgolini, Miriam B. Pérez, Mariela F. Molina, Victor A. Bellini, María J. Hereñú, Claudia B. |
author_facet | Herrera, Macarena L. Deza-Ponzio, Romina Ghersi, Marisa S. de la Villarmois, Emilce A. Virgolini, Miriam B. Pérez, Mariela F. Molina, Victor A. Bellini, María J. Hereñú, Claudia B. |
author_sort | Herrera, Macarena L. |
collection | PubMed |
description | Cognitive dysfunction is one of the most severe nonmotor symptoms of nigrostriatal impairment. This occurs as a result of profound functional and morphological changes of different neuronal circuits, including modifications in the plasticity and architecture of hippocampal synapses. Such alterations can be implicated in the genesis and progression of dementia associated with neurodegenerative diseases including Parkinson-like symptoms. There are few studies regarding cognitive changes in nigrostriatal animal models. The aim of this study was to characterize the onset of memory deficit after induction of neurotoxicity with 6-hydroxydopamine (6-OHDA) and its correlation with hippocampal dysfunction. For this, we bilaterally microinjected 6-OHDA in dorsolateral Caudate-Putamen unit (CPu) and then, animals were tested weekly for working memory, spatial short-term memory, and motor performance. We evaluated tyrosine hydroxylase (TH) as a dopamine marker, aldehyde dehydrogenase 2 (ALDH2), a mitochondria detoxification enzyme and astrocyte glial fibrillar acid protein (GFAP) an immunoreactivity marker involved in different areas: CPu, substantia nigra, prefrontal cortex, and hippocampus. We observed a specific prefrontal cortex and nigrostriatal pathway TH reduction while ALDH2 showed a decrease-positive area in all the studied regions. Moreover, GFAP showed a specific CPu decrease and hippocampus increase of positively stained area on the third week after toxicity. We also evaluated the threshold to induce long-term potentiation in hippocampal excitability. Our findings showed that reduced hippocampal synaptic transmission was accompanied by deficits in memory processes, without affecting motor performance on the third-week post 6-OHDA administration. Our results suggest that 3 weeks after neurotoxic administration, astrocytes and ALDH2 mitochondrial enzyme modifications participate in altering the properties that negatively affect hippocampal function and consequently cognitive behavior. |
format | Online Article Text |
id | pubmed-7263115 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-72631152020-06-10 Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved? Herrera, Macarena L. Deza-Ponzio, Romina Ghersi, Marisa S. de la Villarmois, Emilce A. Virgolini, Miriam B. Pérez, Mariela F. Molina, Victor A. Bellini, María J. Hereñú, Claudia B. ASN Neuro Original Paper Cognitive dysfunction is one of the most severe nonmotor symptoms of nigrostriatal impairment. This occurs as a result of profound functional and morphological changes of different neuronal circuits, including modifications in the plasticity and architecture of hippocampal synapses. Such alterations can be implicated in the genesis and progression of dementia associated with neurodegenerative diseases including Parkinson-like symptoms. There are few studies regarding cognitive changes in nigrostriatal animal models. The aim of this study was to characterize the onset of memory deficit after induction of neurotoxicity with 6-hydroxydopamine (6-OHDA) and its correlation with hippocampal dysfunction. For this, we bilaterally microinjected 6-OHDA in dorsolateral Caudate-Putamen unit (CPu) and then, animals were tested weekly for working memory, spatial short-term memory, and motor performance. We evaluated tyrosine hydroxylase (TH) as a dopamine marker, aldehyde dehydrogenase 2 (ALDH2), a mitochondria detoxification enzyme and astrocyte glial fibrillar acid protein (GFAP) an immunoreactivity marker involved in different areas: CPu, substantia nigra, prefrontal cortex, and hippocampus. We observed a specific prefrontal cortex and nigrostriatal pathway TH reduction while ALDH2 showed a decrease-positive area in all the studied regions. Moreover, GFAP showed a specific CPu decrease and hippocampus increase of positively stained area on the third week after toxicity. We also evaluated the threshold to induce long-term potentiation in hippocampal excitability. Our findings showed that reduced hippocampal synaptic transmission was accompanied by deficits in memory processes, without affecting motor performance on the third-week post 6-OHDA administration. Our results suggest that 3 weeks after neurotoxic administration, astrocytes and ALDH2 mitochondrial enzyme modifications participate in altering the properties that negatively affect hippocampal function and consequently cognitive behavior. SAGE Publications 2020-05-28 /pmc/articles/PMC7263115/ /pubmed/32466659 http://dx.doi.org/10.1177/1759091420925977 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Paper Herrera, Macarena L. Deza-Ponzio, Romina Ghersi, Marisa S. de la Villarmois, Emilce A. Virgolini, Miriam B. Pérez, Mariela F. Molina, Victor A. Bellini, María J. Hereñú, Claudia B. Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved? |
title | Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved? |
title_full | Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved? |
title_fullStr | Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved? |
title_full_unstemmed | Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved? |
title_short | Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved? |
title_sort | early cognitive impairment behind nigrostriatal circuit neurotoxicity: are astrocytes involved? |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263115/ https://www.ncbi.nlm.nih.gov/pubmed/32466659 http://dx.doi.org/10.1177/1759091420925977 |
work_keys_str_mv | AT herreramacarenal earlycognitiveimpairmentbehindnigrostriatalcircuitneurotoxicityareastrocytesinvolved AT dezaponzioromina earlycognitiveimpairmentbehindnigrostriatalcircuitneurotoxicityareastrocytesinvolved AT ghersimarisas earlycognitiveimpairmentbehindnigrostriatalcircuitneurotoxicityareastrocytesinvolved AT delavillarmoisemilcea earlycognitiveimpairmentbehindnigrostriatalcircuitneurotoxicityareastrocytesinvolved AT virgolinimiriamb earlycognitiveimpairmentbehindnigrostriatalcircuitneurotoxicityareastrocytesinvolved AT perezmarielaf earlycognitiveimpairmentbehindnigrostriatalcircuitneurotoxicityareastrocytesinvolved AT molinavictora earlycognitiveimpairmentbehindnigrostriatalcircuitneurotoxicityareastrocytesinvolved AT bellinimariaj earlycognitiveimpairmentbehindnigrostriatalcircuitneurotoxicityareastrocytesinvolved AT herenuclaudiab earlycognitiveimpairmentbehindnigrostriatalcircuitneurotoxicityareastrocytesinvolved |